Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company offers Chinese medicine granules, finished pharmaceutical products, raw materials and excipients, medical devices, medical and healthcare services, and smart supply chain for pharmaceutical and medical devices. It also provides its products in the areas of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases, as well as anti-tumor. Tianjin Chase Sun Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Tianjin, China.
Metrics to compare | 300026 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300026PeersSector | |
---|---|---|---|---|
P/E Ratio | 76.1x | 19.0x | −0.7x | |
PEG Ratio | −1.03 | 0.49 | 0.00 | |
Price/Book | 1.4x | 2.2x | 2.6x | |
Price / LTM Sales | 2.2x | 2.7x | 3.2x | |
Upside (Analyst Target) | −4.1% | 20.8% | 46.4% | |
Fair Value Upside | Unlock | 2.8% | 6.9% | Unlock |